Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The Nebraska experience

A Kessinger1

  • 1University of Nebraska Medical Center, Omaha 68198-3330, USA.

Stem Cells (Dayton, Ohio)
|December 1, 1995
PubMed
Summary
This summary is machine-generated.

Autologous peripheral stem cell transplantation (APSCT) offers hematopoietic rescue. Peripheral stem cells, compared to bone marrow, contain fewer tumor cells and enhanced immune cells, improving recovery.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparison of ISHAGE protocol CD34 cell enumeration with a lineage negative backgating technique.

Cytotherapy·2010
Same author

An ex vivo model of hematopoietic stem cell mobilization.

Cytotherapy·2005
Same author

Immunological and clinical effects of post-transplant G-CSF versus placebo in T-cell replete allogeneic blood transplant patients: results from a randomized double-blind study.

Cytotherapy·2003
Same author

The impact of escalating regulatory requirements on the conduct of clinical research.

Cytotherapy·2003
Same author

Occult tumor cells detected in autologous blood stem cell harvests have no impact on 5 year outcomes for breast cancer patients with 4-9 positive nodes treated with adjuvant high-dose therapy and stem cell transplantation.

Bone marrow transplantation·2003
Same author

The whys and hows of hematopoietic progenitor and stem cell mobilization.

Bone marrow transplantation·2003
Same journal

Brent A. Reynolds, pioneer of adult neural stem cell biology.

Stem cells (Dayton, Ohio)·2026
Same journal

CircVapa promotes the abnormal differentiation of small intestinal epithelial stem cells in diabetic state.

Stem cells (Dayton, Ohio)·2026
Same journal

Transforming Growth Factor beta-2 (TGFβ2) Drives Trabecular Meshwork Progenitor Cell Differentiation Through SMAD2/3 Signalling.

Stem cells (Dayton, Ohio)·2026
Same journal

Circular RNA circEGFR overexpression attenuates chemosensitivity and enhances cancer stemness via targeting IGF2BP2/SOX2 in breast cancer cells.

Stem cells (Dayton, Ohio)·2026
Same journal

Regeneration of the mammalian brain: a relic of evolution?

Stem cells (Dayton, Ohio)·2026
Same journal

Mitochondrial transfer technologies with molecular insights into clinical applications.

Stem cells (Dayton, Ohio)·2026
See all related articles

Area of Science:

  • Hematology
  • Transplant Immunology
  • Oncology

Background:

  • Autologous peripheral stem cell transplantation (APSCT) was developed for hematopoietic rescue in patients with high-dose therapy but unfit bone marrow.
  • Early APSCT (1984-1991) involved steady-state collection without mobilization, showing comparable hematopoietic recovery to autologous marrow, except in patients receiving total body irradiation.

Purpose of the Study:

  • To evaluate the efficacy and characteristics of autologous peripheral stem cell transplantation.
  • To compare peripheral stem cell collections with autologous bone marrow harvests regarding tumor cell contamination, cytotoxic activity, and immune cell populations.

Main Methods:

  • Historical analysis of APSCT outcomes from 1984-1991, comparing recovery with and without total body irradiation.

Related Experiment Videos

  • Analysis of peripheral stem cell apheresis products for tumor cells (cell culture, immunocytochemistry, PCR), antitumor cytotoxic activity, and lymphocyte populations.
  • Comparison of these characteristics with autologous bone marrow harvests.

    • Main Results:

    • Peripheral stem cells restored hematopoietic function similarly to autologous marrow in patients not receiving total body irradiation; slower recovery was observed with total body irradiation.
    • Peripheral stem cell collections contained fewer tumor cells than autologous bone marrow harvests.
    • Peripheral stem cell products exhibited greater antitumor cytotoxic activity and larger immunocompetent lymphocyte populations compared to bone marrow.

    Conclusions:

    • Autologous peripheral stem cell transplantation is a viable option for hematopoietic rescue, with distinct immunological properties compared to bone marrow transplantation.
    • Peripheral stem cell collections offer potential advantages due to reduced tumor cell contamination and enhanced immune cell components.
    • Future directions include graft engineering, focusing on accessory cell function for personalized patient and disease-specific treatments.